Home / Private raises / OrbiMed Private Investments X, LP
OrbiMed Private Investments X, LP
Private Equity Fund · New York, New York · $1.9B sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | D/A (update) | $1.9B | $1.9B | 131 | 506(b), 3(c), 3(c)(7) | Fund interests | Sep 30 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| UBS Switzerland AG | — |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | All States |
No sales commission reported in the latest filing.
Issuer
| Industry | Pooled Investment Fund |
| Fund type | Private Equity Fund |
| Located | New York, New York |
| Entity | Limited Partnership |
| Incorporated | Delaware, 2025 |
| Revenue range | Not Applicable |
| SEC CIK | 2087033 |
People named in the latest filing
| Name | Role |
|---|---|
| OrbiMed Capital GP X, LP | General Partner of the Issuer (the "GPLP") |
| OrbiMed Capital GP X LLC | General Partner of the GPLP (the "GPLLC") |
| OrbiMed Advisors LLC | Managing Member of the GPLLC ("OrbiMed Advisors") |
| Mona Ashiya | Member of OrbiMed Advisors |
| David P. Bonita | Member of OrbiMed Advisors |
| Carl L. Gordon | Member of OrbiMed Advisors |
| Geoffrey C. Hsu | Member of OrbiMed Advisors |
| W. Carter Neild | Member of OrbiMed Advisors |
| Matthew S. Rizzo | Member of OrbiMed Advisors |
| C. Scotland Stevens | Member of OrbiMed Advisors |
| Peter A. Thompson | Member of OrbiMed Advisors |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
